Data gathered: January 28
AI Stock Analysis - SIGA Technologies (SIGA)
Analysis generated January 11, 2025. Powered by Chat GPT.
SIGA Technologies is a company specializing in the development and commercialization of pharmaceutical solutions for unmet medical needs. They primarily focus on providing products for diseases with high unmet needs, and their flagship product is an antiviral drug called TPOXX (tecovirimat), which is used to treat smallpox. The company's business model is built around providing solutions for biosecurity and pandemic response, with a strong emphasis on medication for biological warfare threats and other high-risk infectious diseases.
Stock Alerts - SIGA Technologies (SIGA)
 |
SIGA Technologies | January 14 Price is up by 5.6% in the last 24h. |
|
SIGA Technologies | December 19 Price is up by 5.1% in the last 24h. |
|
SIGA Technologies | December 18 Price is down by -5.6% in the last 24h. |
|
SIGA Technologies | December 11 Price is down by -5.6% in the last 24h. |
Alternative Data for SIGA Technologies
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | N/A | Sign up | Sign up | Sign up |
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 5,000 | Sign up | Sign up | Sign up |
| Employee Rating | 78 | Sign up | Sign up | Sign up |
| Google Trends | 2 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 3 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 7,898 | Sign up | Sign up | Sign up |
| Twitter Followers | 932 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 83 | Sign up | Sign up | Sign up |
| Linkedin Employees | 94 | Sign up | Sign up | Sign up |
About SIGA Technologies
SIGA Technologies, Inc. is an American pharmaceutical company founded in 1995, based in New York City, which develops and sells pharmaceutical solutions for the antiviral treatment of smallpox, monkeypox, cowpox, and vaccinia complications.
| Price | $6.20 |
| Target Price | Sign up |
| Volume | 306,230 |
| Market Cap | $504M |
| Year Range | $5.73 - $11.97 |
| Dividend Yield | 0% |
| PE Ratio | 6.03 |
| Analyst Rating | 0% buy |
| Industry | Drug Manufacturers |
In the news
 |
SIGA Technologies Sees Unusually High Options Volume (NASDAQ:SIGA)January 22 - ETF Daily News |
|
SIGA Technologies, Inc. (NASDAQ:SIGA) Shares Acquired by Harbor Capital Advisors Inc.January 14 - ETF Daily News |
|
SIGA Technologies Target of Unusually High Options Trading (NASDAQ:SIGA)January 9 - ETF Daily News |
 |
SIGA’s antiviral approved in Japan for orthopoxvirus treatmentJanuary 2 - Yahoo |
 |
Japan Approves SIGA Technologies Antiviral As First For Smallpox, MpoxJanuary 2 - Biztoc.com |
|
State Street Corp Has $7.41 Million Stock Holdings in SIGA Technologies, Inc. (NASDAQ:SIGA)December 28 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 10M | 6.4M | 3.6M | 1.3M | 540,000 | 0.019 |
| Q2 '24 | 22M | 18M | 4M | 1.8M | 1.2M | 0.026 |
| Q1 '24 | 25M | 11M | 14M | 10M | 11M | 0.144 |
| Q4 '23 | 116M | 22M | 94M | 72M | 92M | 1.016 |
| Q3 '23 | 9.2M | 6.9M | 2.3M | -390,000 | -1.2M | -0.010 |
Insider Transactions View All
No recorded Insider transactions.
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
Johnson & JohnsonJNJ |
$150.38 1.6% | 50 |
 |
Eli Lilly and CompanyLLY |
$804.99 0.4% | 65 |
 |
PfizerPFE |
$26.75 0.4% | 38 |
 |
AstrazenecaAZN |
$69.59 0.7% | 46 |
 |
AbbVieABBV |
$174.81 1.2% | 47 |
Read more about SIGA Technologies (SIGA) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of SIGA Technologies?
The Market Cap of SIGA Technologies is $504M.
What is SIGA Technologies' PE Ratio?
As of today, SIGA Technologies' PE (Price to Earnings) ratio is 6.03.
What is the current stock price of SIGA Technologies?
Currently, the price of one share of SIGA Technologies stock is $6.20.
How can I analyze the SIGA stock price chart for investment decisions?
The SIGA stock price chart above provides a comprehensive visual representation of SIGA Technologies' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling SIGA Technologies shares. Our platform offers an up-to-date SIGA stock price chart, along with technical data analysis and alternative data insights.
Does SIGA offer dividends to its shareholders?
As of our latest update, SIGA Technologies (SIGA) does not offer dividends to its shareholders. Investors interested in SIGA Technologies should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of SIGA Technologies?
Some of the similar stocks of SIGA Technologies are Johnson & Johnson, Eli Lilly and Company, Pfizer, Astrazeneca, and AbbVie.
.